Inside Malcolm Hebden s life – secret second Corrie role to near-death experience dailystar.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailystar.co.uk Daily Mail and Mail on Sunday newspapers.
VSU 2021 Graduates say goodbye to VSU
May 5, 2021
164 Views
Yet another class of graduating seniors will be crossing the stage at Bazemore-Hyder Stadium to receive their degrees on May 7 and 8. Here are just a few out of the many graduates.
Jenna Becton, Bachelors of Science Degree with a Major in Biology from Hahira, Georgia
“Planning to go to Veterinary school to become a veterinarian. I will miss all my friends that I have made in my sorority, Alpha Sigma Alpha, and I will miss leading and participating in the pre-veterinary club.”
Chadaria Cochran, B.S. Health Science from Perry, Georgia
“I am going on a mission’s trip to Alaska for the entire summer through my organization on campus- Baptist Collegiate Ministry (BCM). Upon returning, I plan on enlisting in the U.S Airforce pursuing a career in Health Services. I will definitely miss the beautiful campus, the palm trees, and the fun/FREE events held for students.”
Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
Oakville, Ontario (Newsfile Corp. - January 21, 2021) - Cardiol Therapeutics Inc. (
Cardiol or the
Company ), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease, today announced the formation of the Data Safety Monitoring Committee ( DSMC ) and the Clinical Endpoint Committee ( CEC ) for the Company s Phase II/III trial in high-risk patients hospitalized with COVID-19 at clinical centers throughout the United States.
The DSMC comprises independent experts who will assess the patient safety data, and, if needed, critical efficacy endpoints of the trial. In order to do so, the DSMC may review unblinded study information (on a patient level or treatment group lev